Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Pickles

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British ColumbiaGreg Hapgood, Yvonne Zheng, Laurie H Sehn, et al.
Blood|July 1, 2020
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approachAnna R Hayden, Petter Tonseth, Derrick G Lee, et al.
Blood|September 2, 2020
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOPCiara L Freeman, Kerry J Savage, Diego R Villa, et al.
Blood Advances|August 26, 2021
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approachPhoebe T M Cheng, Diego Villa, R Petter Tonseth, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
European Urology|November 20, 2012
Active surveillance for low-risk prostate cancer worldwide: the PRIAS studyMeelan Bul, Xiaoye Zhu, Riccardo Valdagni, et al.
BJU International|October 13, 2009
Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' studyRoderick C N van den Bergh, Hanna Vasarainen, Henk G van der Poel, et al.
Critical Reviews in Oncology/Hematology|August 11, 2012
Active surveillance for low-risk prostate cancerChris H Bangma, Meelan Bul, Theo H van der Kwast, et al.
European Urology Oncology|June 16, 2019
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future StudiesTheo H van der Kwast, Jozien Helleman, Daan Nieboer, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British ColumbiaGreg Hapgood, Yvonne Zheng, Laurie H Sehn, et al.
Blood|July 1, 2020
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approachAnna R Hayden, Petter Tonseth, Derrick G Lee, et al.
Blood|September 2, 2020
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOPCiara L Freeman, Kerry J Savage, Diego R Villa, et al.
Blood Advances|August 26, 2021
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approachPhoebe T M Cheng, Diego Villa, R Petter Tonseth, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
European Urology|November 20, 2012
Active surveillance for low-risk prostate cancer worldwide: the PRIAS studyMeelan Bul, Xiaoye Zhu, Riccardo Valdagni, et al.
BJU International|October 13, 2009
Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' studyRoderick C N van den Bergh, Hanna Vasarainen, Henk G van der Poel, et al.
Critical Reviews in Oncology/Hematology|August 11, 2012
Active surveillance for low-risk prostate cancerChris H Bangma, Meelan Bul, Theo H van der Kwast, et al.
European Urology Oncology|June 16, 2019
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future StudiesTheo H van der Kwast, Jozien Helleman, Daan Nieboer, et al.
Pageof 14